JP2025511167A5 - - Google Patents
Info
- Publication number
- JP2025511167A5 JP2025511167A5 JP2024557991A JP2024557991A JP2025511167A5 JP 2025511167 A5 JP2025511167 A5 JP 2025511167A5 JP 2024557991 A JP2024557991 A JP 2024557991A JP 2024557991 A JP2024557991 A JP 2024557991A JP 2025511167 A5 JP2025511167 A5 JP 2025511167A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- myostatin
- sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22166261 | 2022-04-01 | ||
| EP22166261.2 | 2022-04-01 | ||
| PCT/EP2023/058218 WO2023187022A1 (en) | 2022-04-01 | 2023-03-30 | New treatment for facioscapulohumeral muscular dystrophy (fshd) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511167A JP2025511167A (ja) | 2025-04-15 |
| JP2025511167A5 true JP2025511167A5 (enExample) | 2026-04-07 |
Family
ID=81328333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557991A Pending JP2025511167A (ja) | 2022-04-01 | 2023-03-30 | 顔面肩甲上腕型筋ジストロフィー（ｆｓｈｄ）の新規な処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250171526A1 (enExample) |
| EP (1) | EP4504779A1 (enExample) |
| JP (1) | JP2025511167A (enExample) |
| KR (1) | KR20240165959A (enExample) |
| CN (1) | CN119053619A (enExample) |
| AU (1) | AU2023246859A1 (enExample) |
| CA (1) | CA3255735A1 (enExample) |
| IL (1) | IL315473A (enExample) |
| MX (1) | MX2024011922A (enExample) |
| TW (1) | TW202346345A (enExample) |
| WO (1) | WO2023187022A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026147753A1 (en) * | 2024-12-30 | 2026-07-09 | Scholar Rock, Inc. | Therapies for muscular dystrophies |
| US20260199503A1 (en) | 2025-01-10 | 2026-07-16 | Regeneron Pharmaceuticals, Inc. | Glp1r agonist-tethered gdf8 antibody conjugates and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| MX2017005774A (es) | 2014-12-19 | 2017-07-28 | Chugai Pharmaceutical Co Ltd | Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso. |
| EA201891420A1 (ru) | 2015-12-18 | 2019-02-28 | Чугаи Сейяку Кабусики Кайся | Антитела к миостатину, полипептиды, содержащие варианты fc-областей, и способы их применения |
-
2023
- 2023-03-30 WO PCT/EP2023/058218 patent/WO2023187022A1/en not_active Ceased
- 2023-03-30 TW TW112112383A patent/TW202346345A/zh unknown
- 2023-03-30 KR KR1020247032600A patent/KR20240165959A/ko active Pending
- 2023-03-30 CA CA3255735A patent/CA3255735A1/en active Pending
- 2023-03-30 JP JP2024557991A patent/JP2025511167A/ja active Pending
- 2023-03-30 EP EP23716257.3A patent/EP4504779A1/en active Pending
- 2023-03-30 IL IL315473A patent/IL315473A/en unknown
- 2023-03-30 AU AU2023246859A patent/AU2023246859A1/en active Pending
- 2023-03-30 CN CN202380032060.9A patent/CN119053619A/zh active Pending
-
2024
- 2024-09-27 MX MX2024011922A patent/MX2024011922A/es unknown
- 2024-09-30 US US18/902,642 patent/US20250171526A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024016177A5 (enExample) | ||
| JP2020518599A5 (enExample) | ||
| JP2023109942A5 (enExample) | ||
| JP2023517236A5 (enExample) | ||
| FI4045533T3 (fi) | Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2) | |
| JP2019534003A5 (enExample) | ||
| JP2025032102A5 (enExample) | ||
| JP2022523972A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2006522830A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| JP2021501579A5 (enExample) | ||
| JP2025514978A5 (enExample) | ||
| JP2024537864A5 (enExample) | ||
| JP2018506966A5 (enExample) | ||
| JP2025509266A5 (enExample) | ||
| JP2024518536A5 (enExample) | ||
| JP2021532176A5 (enExample) | ||
| JP2024540226A5 (enExample) | ||
| JP2020533382A5 (enExample) | ||
| JP2023510199A5 (enExample) | ||
| JP2021523138A5 (enExample) | ||
| JP2024540395A5 (enExample) | ||
| JP2022535523A5 (enExample) | ||
| JP2023511956A5 (enExample) |